Ibrutinib Has Some Activity in Richter’s Syndrome

Blood Cancer Journal - United States
doi 10.1038/bcj.2014.98
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ibrutinib Plus Palbociclib Has Efficacy in Mantle Cell Lymphoma

Cancer Discovery
Oncology
2019English

Richter’s Hernia: A Case Report

Journal of the Liaquat University of Medical and Health Sciences
Medicine
2019English

Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia (CLL)

Clinical Cancer Research
Cancer ResearchOncology
2019English

Camrelizumab Has Activity in Patients With Nasopharyngeal Carcinoma

Cancer Discovery
Oncology
2018English

Tissue Transglutaminase Has Intrinsic Kinase Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Exerts Immunomodulatory Activity Towards Tumor-Infiltrating Macrophages

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Parsaclisib Has Activity in Patients With B-Cell Malignancies

Cancer Discovery
Oncology
2019English

Vemurafenib Has Activity in Patients With BRAFV600-Mutant Glioma

Cancer Discovery
Oncology
2018English

Larotrectinib Has Antitumor Activity in TRK + Pediatric Solid Tumors

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy